Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke (P_Dysport_CS)
Cost Determination Study For Different Botulinum Toxin A Preparations In The Treatment Of Upper Limb Spasticity Post-Stroke In Portugal
Sponsor: Ipsen
Listed as NCT02384330, this observational or N/A phase trial focuses on Upper Limb Spasticity Post-Stroke and remains completed. Sponsored by Ipsen, it has been updated 9 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Feb 2019 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Feb 2019 [monthly]
Completed
▶ Show 4 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2017 — Jan 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Nov 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ipsen
For direct contact, visit the study record on ClinicalTrials.gov .